BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 19415945)

  • 1. Recurrent challenges in the evaluation of fibroepithelial lesions.
    Giri D
    Arch Pathol Lab Med; 2009 May; 133(5):713-21. PubMed ID: 19415945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibroepithelial lesions; The WHO spectrum.
    Krings G; Bean GR; Chen YY
    Semin Diagn Pathol; 2017 Sep; 34(5):438-452. PubMed ID: 28688536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Diagnostic Approach to Fibroepithelial Breast Lesions.
    Tan BY; Tan PH
    Surg Pathol Clin; 2018 Mar; 11(1):17-42. PubMed ID: 29413655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Collagen type III α1 as a useful diagnostic immunohistochemical marker for fibroepithelial lesions of the breast.
    Wang Y; Resnick MB; Lu S; Hui Y; Brodsky AS; Yang D; Yakirevich E; Wang L
    Hum Pathol; 2016 Nov; 57():176-181. PubMed ID: 27498063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A five-gene reverse transcription-PCR assay for pre-operative classification of breast fibroepithelial lesions.
    Tan WJ; Cima I; Choudhury Y; Wei X; Lim JC; Thike AA; Tan MH; Tan PH
    Breast Cancer Res; 2016 Mar; 18(1):31. PubMed ID: 26961242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroepithelial lesions revisited: implications for diagnosis and management.
    Tan PH
    Mod Pathol; 2021 Jan; 34(Suppl 1):15-37. PubMed ID: 32461622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibroepithelial lesions of the breast: a comprehensive morphological and outcome analysis of a large series.
    Slodkowska E; Nofech-Mozes S; Xu B; Parra-Herran C; Lu FI; Raphael S; Zubovits J; Hanna W
    Mod Pathol; 2018 Jul; 31(7):1073-1084. PubMed ID: 29449684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular fibroepithelial lesions of the breast: A long term follow up study.
    Yasir S; Nassar A; Jimenez RE; Jenkins SM; Hartmann LC; Degnim AC; Frost M; Visscher DW
    Ann Diagn Pathol; 2018 Aug; 35():85-91. PubMed ID: 30029048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a Management Algorithm for the Diagnosis of Cellular Fibroepithelial Lesions From Core Needle Biopsies.
    Jung J; Kang E; Chae SM; Kim H; Park SY; Yun B; Kim SM; Jang M; Kim SW; Kim EK
    Int J Surg Pathol; 2018 Dec; 26(8):684-692. PubMed ID: 29774785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phyllodes Tumor of the Breast: Histopathologic Features, Differential Diagnosis, and Molecular/Genetic Updates.
    Zhang Y; Kleer CG
    Arch Pathol Lab Med; 2016 Jul; 140(7):665-71. PubMed ID: 27362571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pathological features and clinicopathological significance of TERT promoter mutation in breast fibroepithelial tumors without definite diagnosis].
    Wang JG; Hu YJ; Guan JJ; Liu HY; Bi ZJ; Zhang LX; Liu YX; Xing XM
    Zhonghua Bing Li Xue Za Zhi; 2023 Feb; 52(2):153-159. PubMed ID: 36748136
    [No Abstract]   [Full Text] [Related]  

  • 12. Proliferating activity in differential diagnosis of benign phyllodes tumor and cellular fibroadenomas: is it helpful?
    Kaya R; Pestereli HE; Erdogan G; Gülkesen KH; Karaveli S
    Pathol Oncol Res; 2001; 7(3):213-6. PubMed ID: 11692149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Core needle biopsy diagnosis of fibroepithelial lesions of the breast: a diagnostic challenge.
    Li JJX; Tse GM
    Pathology; 2020 Oct; 52(6):627-634. PubMed ID: 32771211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroepithelial tumours of the breast-a review.
    Lerwill MF; Lee AHS; Tan PH
    Virchows Arch; 2022 Jan; 480(1):45-63. PubMed ID: 34505197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroadenoma With Pleomorphic Stromal Giant Cells: It's Not as Bad as It Looks!
    Wawire J; Singh K; Steinhoff MM
    Int J Surg Pathol; 2017 Aug; 25(5):425-427. PubMed ID: 28413897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibroepithelial lesions of the breast with pleomorphic stromal giant cells: a clinicopathologic study of 4 cases and review of the literature.
    Huo L; Gilcrease MZ
    Ann Diagn Pathol; 2009 Aug; 13(4):226-32. PubMed ID: 19608080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic stromal histomorphology in fibroepithelial breast lesions: a fresh perspective.
    Aiyer HM; Jain M; Thomas S; Logani KB
    Indian J Pathol Microbiol; 2000 Jan; 43(1):5-12. PubMed ID: 12583412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibroepithelial lesions of the breast: A review of recurring diagnostic issues.
    Seow DYB; Tay TKY; Tan PH
    Semin Diagn Pathol; 2022 Sep; 39(5):333-343. PubMed ID: 35523613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinction of phyllodes tumor from fibroadenoma: a reappraisal of an old problem.
    Krishnamurthy S; Ashfaq R; Shin HJ; Sneige N
    Cancer; 2000 Dec; 90(6):342-9. PubMed ID: 11156517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA methylation profiling of phyllodes and fibroadenoma tumours of the breast.
    Huang KT; Dobrovic A; Yan M; Karim RZ; Lee CS; Lakhani SR; Fox SB
    Breast Cancer Res Treat; 2010 Nov; 124(2):555-65. PubMed ID: 20563638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.